| NCT ID | NCT05500573 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Weill Medical College of Cornell University |
| Condition | Infertility |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2013-11-06 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,000 participants in total. It began in 2013-11-06 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to demonstrate a reliable method of selecting gender specific sperm. X-bearing spermatozoa and Y-bearing spermatozoa will be identified from the density gradient layers. The selected gender specimen will then be utilized for assisted reproductive fertilization- in vitro fertilization or intrauterine insemination which are routine standard of care procedures.
Eligibility Criteria
Inclusion Criteria: * Couples undergoing infertility treatment with IVF or insemination seeking gender specific offspring for medical and non medical reasons Exclusion Criteria: * Severe male factor
Contact & Investigator
Gianpiero Palermo, MD, PhD
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT05500573 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 89 Years, studying Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05500573 currently recruiting?
Yes, NCT05500573 is actively recruiting participants. Contact the research team at res2011@med.cornell.edu for enrollment information.
Where is the NCT05500573 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT05500573 clinical trial?
NCT05500573 is sponsored by Weill Medical College of Cornell University. The principal investigator is Gianpiero Palermo, MD, PhD at Weill Medical College of Cornell University. The trial plans to enroll 2,000 participants.